Innotec — Equipment for particulate systems and bioprocess analysis

Quality Control

This industry does not have details for the selected language yet.

Quality Control

This industry does not have details for the selected language yet.

Industry overview

Use this space to highlight how your equipment and services solve challenges for this industry. Tailor the description per locale to address regional needs and regulatory nuances.

Add links, documents, or success stories relevant to this segment. Keeping translations aligned ensures your message resonates across markets.

Related articles

5 5 articles
19 Oct 2026 0 no read time

Parenteral Solutions in Argentina: What Changes Under ANMAT Regulation 5146/2026?

ANMAT Regulation 5146/2026 clarifies the requirements for closed manufacturing systems used in large-volume parenteral solutions. Learn how these requirements relate to pharmaceutical quality control and subvisible particle testing.

Read more
13 Oct 2026 0 no read time

Subvisible Particles in Injectables: Analytical Criteria and Compliance with the Argentine Pharmacopoeia

Technical review of Argentine Pharmacopoeia requirements for subvisible particles in injectables, covering sample preparation, acceptance criteria, analytical limitations and HIAC 9703+ applications.

Read more
07 Oct 2026 0 no read time

Beckman Coulter in Argentina: INNOTEC, Exclusive Distributor of the Particle Counting Product Line

INNOTEC is Beckman Coulter’s partner and exclusive distributor for the particle counting product line in Argentina. Discover MET ONE, HIAC and Multisizer 4e solutions, their applications and associated technical services.

Read more
21 Sep 2026 0 no read time

ANMAT: What Is Required in a Good Manufacturing Practices Inspection

ANMAT Disposition 4159/23 defines GMP requirements for pharmaceutical manufacturers in Argentina, covering quality systems, facilities, equipment, documentation, qualification, validation and quality control.

Read more
09 Sep 2026 0 no read time

Why do some surfactants better protect therapeutic proteins against agitation-induced aggregation?

Protein and surfactant compete for the same air/water interface, and whichever arrives first determines the fate of the batch. Adsorption kinetics, not CMC, correlates with agitation-induced aggregation.

Read more

Stay in the loop

Get updates, articles and news by email.